S2EP4: That's a Check I'm Not Willing To Take with Marissa Fayer

She had nine commercial partners, FDA clearance, and a 25-year medtech track record. Still an investor stopped her mid-pitch to ask whether breast cancer was “still a thing.” In this episode of The Capital Flex, I sit down with Marissa Fayer, engineer, operator, and CEO of Deep Look Medical, an FDA-cleared imaging software company helping radiologists visualize soft tumors in dense tissue with a single click. Marissa shares what it looked like to raise capital through one of the toughest fund...